PROTECH REMEDIES PRIVATE LIMITED
PROTECH REMEDIES PRIVATE LIMITED is a HARYANA based PRIVATE LIMITED company, Registered at dated 02-JUN-2023 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of PROTECH REMEDIES PRIVATE LIMITED is U21002HR2023PTC112261 and registration number is 112261.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC DELHI India. Authorized share capital of PROTECH REMEDIES PRIVATE LIMITED is Rs. 1500000 and its paid up capital is Rs. 100000. It aspire to serve in MANUFACTURE OF ALLOPATHIC PHARMACEUTICAL PREPARATIONS activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
PROTECH REMEDIES PRIVATE LIMITED has 2 directors ASHA DHINGRA, ANIKET DHINGRA,
The registered Email address of PROTECH REMEDIES PRIVATE LIMITED is Books.ynr@gmail.com and its registered address is SCO-36, SECTOR-17, HUDA JAGADHRI, HARYNA JAGADHRI TOWN JAGADHRI YAMUNA NAGAR HR 135003 IN HARYANA HARYANA india 135003.
The current status of PROTECH REMEDIES PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
PROTECH REMEDIES PRIVATE LIMITED
ROC DELHI
ACTIVE
MANUFACTURE OF ALLOPATHIC PHARMACEUTICAL PREPARATIONS
U21002HR2023PTC112261
02-JUN-2023
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1500000
100000
CONTACT DETAILS
135003
INDIA
SCO-36, SECTOR-17, HUDA JAGADHRI, HARYNA JAGADHRI TOWN JAGADHRI YAMUNA NAGAR HR 135003 IN
Books.ynr@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
03028552 | ASHA DHINGRA | Director | 02/06/2023 |
08660951 | ANIKET DHINGRA | Director | 02/06/2023 |
Details Updated by Companies
Quick Links
- All Registered company of HARYANA
- Company Registered in HARYANA
- All Registered company of YAMUNANAGAR in HARYANA
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.